Jean Laurent Poitou appointed as new CEO of Ipsos

Published 19/08/2025, 17:18
Jean Laurent Poitou appointed as new CEO of Ipsos

PARIS - Market research firm Ipsos (EPA:IPS), a $1.95 billion market cap company with annual revenues of $2.89 billion, announced Tuesday the appointment of Jean Laurent Poitou as its new Chief Executive Officer, effective September 15, replacing current CEO Ben Page.

The Board of Directors made the decision during a meeting held Tuesday morning, citing the need to give Ipsos "the momentum needed to adopt and implement a realistic and credible growth plan" amid evolving market demands. According to InvestingPro data, the company maintains a GOOD financial health score despite experiencing a -28.54% one-year return.

Poitou, an engineer and graduate of École Polytechnique, brings over 30 years of experience from Accenture where he held senior international management positions across Europe, the United States, and Asia. For the past four years, he has led the Digital and Technology Services practice at Alvarez & Marsal across Europe, the Middle East and Africa.

The Board emphasized that while the market for research services remains strong, client demands are shifting toward faster data delivery and analysis, regardless of whether information comes from human sources or digital models powered by artificial intelligence.

"I am delighted and determined to lead Ipsos into the next chapter of its growth," Poitou said in the press release statement. "We will build for our clients an increasingly differentiated market and opinion research company, powered by science, technology, artificial intelligence, while remaining true to the values that have made Ipsos’ success."

Page, who will remain CEO until September 15, has spent 38 years at Ipsos, joining MORI (now Ipsos UK) as a trainee before serving as CEO of the UK and Ireland business and then as Global CEO since 2021.

"Now is a good time to hand over the reins at the age of 60," Page stated in the announcement.

Ipsos, founded in France in 1975, is one of the world’s largest market research companies with operations in 90 markets and approximately 20,000 employees. The company has been listed on Euronext Paris since July 1, 1999. Trading at an attractive P/E ratio of 9.27 and offering a robust 4.86% dividend yield, InvestingPro analysis suggests the stock is currently undervalued. For detailed valuation metrics and additional insights, check out the Most Undervalued Stocks list.

In other recent news, Ipsos has announced the acquisition of InMoment’s Healthcare division in Germany. This move is set to enhance Ipsos’s capabilities in the pharmaceutical and medical technology sectors. The acquisition will establish a new competence center for Ipsos’s Healthcare Service Line in Hamburg. This addition complements Ipsos’s existing locations in Nuremberg, Munich, and Frankfurt. The company has not disclosed the financial terms of the acquisition. This strategic expansion indicates Ipsos’s commitment to strengthening its presence in the healthcare market.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.